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Abstract
Background: Carbamazepine (CBZ) is a first-line antiepileptic drug (AED), although it is also used for the
treatments of psychiatric disorders and neuropathic pain. The CBZ utilization has been associated with male
reproductive damage, including hormonal alterations, sexual dysfunction and reduction of sperm quality. The wide
and long-term use of the CBZ is a common schedule in children and adolescents and alters the testosterone level
in adult rats and humans. The objective of this work was to evaluate the CBZ side effects on the ventral prostate
of rats from pre-puberty to sexual maturation, since the prostate is an androgen-dependent organ.
Methods: Twenty three day-old male albino Wistar rats received CBZ diluted in propylene glycol (20 mg/Kg/i.p
via). The treatment lasted 20, 40 and 70 days, according to the different stages of the rat sexual maturation. At the
end of each treatment period, ventral prostates were removed and histologically processed. The prostate sections
were submitted to the histopathological, morphological and stereological analyses using image analysis system.
Results: Reductions of the glandular epithelium, glandular lumen and fibromuscular stroma volume of the ventral
prostate were observed in adult rats treated with CBZ since the weaning. Triggering and degranulation of mast
cells were observed in the fibromuscular stroma of prepubertal and pubertal CBZ treated rats.
Conclusions: The results suggest a direct effect of the CBZ on rat ventral prostate, evidenced by increase of mast
cell and macrophage populations during pre-puberty and puberty causing a ventral prostate accentuated damage
in the adult phase.
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Background
Reproductive endocrine disorders and sexual dysfunc-
t i o na r ec o m m o ni nm e nw i t he p i l e p s y[ 1 ] .I na d d i t i o n ,
these disorders have been frequently associated with
long-term treatments with antiepileptic drugs (AED)
[2-4]. CBZ is a first-line AED also utilized for treatment
of psychiatric disorders such as bipolar affective disorder
[5], alcohol withdrawal syndrome [6] and neuropathic
pain [7].
Various clinical and experimental studies involving the
effects of CBZ and other AED on male reproduction
have been carried out. They have mainly shown hormo-
nal changes and seminal alterations during adult phase,
including reduced sperm motility, sperm morphological
alterations and decrease in the sperm concentration
[8-10]. However, studies have not investigated the
occurrence of damage to the prostate in the phase of
sexual maturation when the CBZ is chronically adminis-
tered from the pre-pubertal phase.
The reproductive hormone status differs noticeably in
humans, according to the phase considered, i.e., in
childhood, adolescence and adulthood. Thus, endocrine
changes due to long-term CBZ-treatments may cause a
negative impact on pubertal development and fertility
both in boys and young men [11]. Damage on the semi-
niferous epithelium, testicular interstitial oedema, reduc-
tions of testosterone levels and increase of estradiol
levels were also observed in rats treated with CBZ since
weaning [12].
The onset and maintenance of prostatic development
are androgen-dependent phenomena [13]. However, in
rodents, the prostatic development is also sensitive to
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The prostate secretion is important for normal male
reproductive function as well as sperm survival within
the female reproductive tract during fertilization [14].
The responsive morphological alterations of the pros-
tate to androgen deprivation caused by diabetes [17],
chronic alcoholism [18], nicotine [19] and castration
[16,20-22] have been shown. In addition, as the chronic
administration of CBZ is a common schedule utilized
for treatment of children and adolescents [11] and can
provoke hormonal alterations as well as damage on fer-
tility [8-12]. In addition, given that there are not studies
investigating the extension of the prostatic damage,
caused by CBZ chronic administration, during the sex-
ual maturation, we assumed that this theme is an essen-
tial subject to be investigated. Thus, considering that the
maturation of the hypothalamic-pituitary-gonadal (HPG)
axis in pre-puberty and puberty is more susceptible to a
cytotoxic agent [12,23,24] and also, taking into account
that recently we observed estrogen and testosterone
level alterations in CBZ-treated rats from the weaning
[12], we proposed to evaluate the side effects of CBZ on
the ventral prostate of rats in different phases of sexual
development; for this goal, the CBZ was administered to
rats from the pre-puberty until the adulthood and the
histopathological, morphometric and stereological ana-
lyses of their prostate ventral lobe were carried out.
Methods
Animals
Thirty 23-day old male Wistar albino rats were used.
The rats were housed in polypropylene cages (40 × 30 ×
15 cm) (4 per cage) and had free access to water and
commercial lab chow (Labina, Purina). The animals
were maintained under controlled photoperiod (12 h
light; 12 h dark), humidity (70%) and temperature (22°-
23°C). The experimental protocol followed the ethical
principles adopted in animal researches by the Brazilian
College of Animal Experimentation. The schedule con-
cerning animal care and treatment was approved by the
Institutional Ethical Committee of São Paulo University.
Experimental schedules
The animals were randomly distributed into six groups
with 5 animals each. The rats were distributed into
three control groups (C43, C63 and C93) and three
CBZ-treated groups (CBZ43, CBZ63 and CBZ93). Trea-
t e dr a t sr e c e i v e dC B Z( C - 8 9 8 1 ,S i g m aC h e m i c a lC o . ,S t .
Louis, MO; 99.5% purity) diluted in propylene glycol (20
mg/ml). The CBZ dose of 20 mg/kg, daily administered
by intraperitoneal route (i.p.), corresponds to the usual
anticonvulsive dose in humans which is effective in pre-
venting kindled seizure in Wistar rats [25,26]. The treat-
ment lasted 20, 40 and 70 days, according to the
different stages of the rats’ sexual maturation, i.e., ado-
lescence (around 43 days; [12,27]), puberty (63 days;
[28,29]) and young adult phase (93 days; [30]). Control
animals received only propylene glycol (vehicle of CBZ).
Body weights of control and experimental rats were
obtained on alternate days.
Histological procedures
At the end of the different treatment periods, the rats
were anesthetized with sodic thiopental (1 ml/kg, Thio-
pentax, Cristália, Lote 06053324). Heparin (1 ml/Kg)
was administered 15 minutes before the euthanasia with
anesthetic superdosage (sodic thiopental 3 mg/kg, i.p.),
by i.p. route. Blood of the rats was collected from the
inferior cava vein and the plasma separated and stored
at -20°C for further hormonal analyses. The ventral
prostate was removed and weighed. The ventral prostate
relative weight (mg of ventral prostate weight/100 g of
body weight) was also calculated. The volume of the
ventral prostate (Vt) was obtained according to DeKlerk
& Coffey’s methodology [31], which assumes that the
specific gravity of the prostate is 1.0 and thus, 1.0 mg
fresh prostate has an approximate volume of 1.0 mm
3.
The ventral prostates were adequately fixed by immer-
sion in Bouin’s liquid for 48 hours. Prostatic fragments
were Paraplast Plus-embedded (P-3683, Sigma Chemical
Co., St. Louis, MO, lote 41K0101); five micrometers-
thick cross sections were obtained and stained using
Mallory Tricromic, for subsequent morphometric and
stereological studies. In addition, other five sections
were obtained and exposed to toluidine blue staining
method and to Perl’s solution labeling for respective
stereological evaluation and the obtainment of the mast
cells and macrophage numerical densities.
Fragments were also embedded in glycol methacrylate
resin (Leica Historesin embedding kit); two micrometer-
thick longitudinal sections were obtained and submitted
to the Hematoxilin and Eosin (HE) staining method for
histopathological analysis under light microscope.
Macrophage labeling
For macrophage labeling, paraplast-embedding tissue
sections were immersed in Perl’s solution containing 2%
potassium ferrocyanide and 2% HCl at a 1:1 concentra-
tion for 30 min [32]. After PBS rinses and 30 min incu-
bation in 3% hydrogen peroxide/PBS, iron was
visualized using 3,3-diaminobenzidine (DAB; Vector) for
30 min at room temperature in the dark [33].
Morphometric and stereological evaluation
Samples of the ventral prostate were obtained according
to the orientator to produce an isotropic uniform ran-
dom (IUR) sample [34,35]. Each ventral prostate sample
was divided into parallel slabs of roughly equal length
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angle at which the first slab was cut was chosen at ran-
dom and other slabs were cut in similar fashion after
systematically rotating on the horizontal plane, provid-
ing an isotropic uniform random section plane. The IUR
sections are more random than vertical sections and
therefore can be used as vertical sections with cycloids
for estimation of length and surface [36].
The morphometric and stereological analyses of the
compartments of the prostate ventral lobe were carried
out. The volume densities (Vv)o ft h el u m e n[Vv(lu)],
glandular epithelium or acinar parenchyma [Vv(ep)] and
fibromuscular stroma [Vv(st)] were calculated using a
Leica QWin (Cambridge, England) image analysis system.
Twenty two fields were systematically randomly sampled
and the images were captured using a digital camera con-
nected to a light microscope. Examination of isotropic uni-
form random (IUR) sections of the ventral prostate
revealed that the glandular tubules were randomly placed
[20]. The Delesse Principle states that the planimetric frac-
tion of a section, which is occupied by sections of a speci-
fied component, corresponds to the fraction of the tissue
volume occupied by the same component [37]. For that
reason, according to the basic principle of stereology, the
area density of the profiles (AA), which measures the rela-
tive occupation of test-area for the area of the images of
the structure under evaluation, is comparable to the
volume density (Vv), i.e., the density of profiles in relation
to the space; consequently, Vv and AA have similar inter-
pretation [37-40]. Thus, from the captured images, the
ventral prostate lumen, glandular epithelium and fibro-
muscular stroma areas were delineated, utilizing the image
analysis system. Then, based on the principles of stereol-
ogy, each specific volume density (Vv) was respectively
obtained by the ratio of the delineated area of the ventral
prostate (lumen, glandular epithelium or fibromuscular
stroma compartment) to the total area of the prostate
component analyzed. In addition, the volumes (V)o ft h e
lumen (Vlu), glandular epithelium (Vep) and fibromuscu-
lar stroma (Vst) of the ventral prostate were estimated by
multiplying each respective volume density (in percentage)
by the prostate total volume (in “Histological procedures”
item) and dividing the result by 100 [29].
The determination of length density (Lv) of the glandu-
lar tubule (Lvgt) and surface density of the glandular
epithelium tubule (Svgt) were also performed [21]. To
measure the length density of the glandular tubules
(Lvgt), we firstly calculated the profile density of the
structure evaluated (QA), i.e., the number of glandular
tubule profiles per area unit was counted. For this pur-
pose, an amount of images of these structures (sections
of glandular tubules) was estimated in a certain test-area
defined by an unbiased counting frame with inclusion
(right and upper) and exclusion (left and lower) borders;
thus, a reliable square test-area was superimposed on the
microscopic images IUR ventral prostate section cap-
tured and shown by the monitor screen of the image ana-
lysis system. Twenty two fields were systematically
randomly sampled. Following, the number of glandular
tubule profiles inside the total test area was counted
(QA). All structures falling on the two set forbidden lines
were not counted to avoid overestimation. Subsequently,
the glandular tubule length density (Lvgt) was obtained
by the formula: Lvgt =2*Q A [35]. The total length (L) of
glandular tubules (Lgt) was also calculated using the for-
mula: Lgt =L v gt xV t ,w h e r eL v gt corresponds to the
glandular tubule length density [35] and Vt is the ventral
prostate total volume obtained as formerly referred. The
total area analyzed was obtained by multiplying the area
of the test grid (1874.75 mm
2)b yt h en u m b e ro ff i e l d s
analyzed (23 fields) utilizing ×20 objective lens.
The surface density of the glandular epithelium Svep
was obtained by counting the number of intercepts of
the cycloid test lines with luminal border of the glandu-
lar epithelium using a cycloid test grid [37]. Then, the
glandular epithelium surface (Sep) was calculated by
multiplying Svep by the ventral prostate total volume
(Vt) and dividing this result by 100 [20].
Numerical densities of mast cells and macrophages
Twenty two fields were systematically randomly sampled
and the images were captured using a computer assisted
image analysis system (Leica-Q550IW; Cambridge-Eng-
land) coupled to a light microscope. Both macrophage
(Perl’s solution labeling) and mast cells (toluidine blue
staining) counts were attained by Optical Disector
method. Considering that the numerical density (Nv) is
expressed by units of volume and corresponds to the ratio
of total number of scored cells to total volume of tissue
examined (V), the numbers of macrophage and mast cells
per mm
3 of fibromuscular stroma were obtained. The
volume of the fibromuscular stroma (v) was estimated by
multiplying the respective areas delineated (in mm
2)b y
thickness cross sections (in mm). Thus, the numerical
d e n s i t y( N v )i se x p r e s s e db yu n i t so fv o l u m ea n dc o r r e -
sponds to the ratio between the total number of scored
macrophage/mast cells and volume of fibromuscular
stroma examined. Counts of macrophage and mast cells
were conducted. To avoid overestimation, we scrutinized
the testicular tissue by focusing only on one chosen plane
(the look-up plane; [41]); thus, only the tissue viewed on
this plane was submitted to stereological analysis [42].
Immunohistochemistry (IHC)
AR (SC-816, rabbit polyclonal IgG, epitope mapping at
the N-terminus of AR, Santa Cruz Biotechnology, USA)
primary antibody was used for immunohistochemistry
(IHC). The IHC reaction was performed using the
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nology, CA, USA). For the immunohistochemical tech-
nique, the ventral prostate fragments were previous
adequately fixed by immersion in Bouin’sl i q u i da n d
processed for paraplast-plus embedding (P-3683; Sigma
Chemical Co., lote 41K0101). The sections (5 μm) were
dewaxed and then rehydrated in alcohol graded solution
and distilled water. Antigenic retrieval was realized in
citrate buffer at high temperature (100°C) for 45 min-
utes. Endogenous peroxidase activity was blocked with
0.3% hydrogen peroxide in methanol for 45 min, fol-
lowed by a quick rinse in distilled water and phosphate-
buffered saline (PBS), and then incubated in 1% bovine
serum in PBS for 1 h, to block non-specific binding.
Sections were incubated with the primary antibody at 4°
C overnight. The slides were then incubated with bioti-
nylated secondary antibody at 37°C followed by peroxi-
dase-conjugated avidin-biotin complexes and
diaminobenzidine (DAB). The sections were then coun-
terstained with Harris’s hematoxylin. For negative con-
trol, the primary antibody was replaced with the
corresponding normal isotype serum.
AR semi-quantitative analysis
At least five histological sections were analyzed per
group and AR positive nuclei were randomly selected by
section (100 nuclei/group). The images of the selected
nuclei were cut in a regular and constant rectangular
form (always in central part of the nucleus, in view of
the homogeneity of nuclear staining/reactivity for AR)
and those “rectangles” were submitted to optical densi-
tometry analysis by Scion Image for Windows Soft-
ware
®. The integrated optical density (IOD)
methodological proceedings were based on physical
principles of quantification performed [39].
Hormonal levels
Testosterone and estradiol plasmatic levels were deter-
mined by radioimmunoassay method using Coat-A-
Count Total Testosterone kit and Coat-A-Count Total
Estradiol kit (Diagnostic Products Corp., LA, CA, USA).
The sensitivity of all Kits utilized was 0.01 ng/mL.
Statistical analysis
Data obtained from the treated and control groups were
compared using two-way ANOVA; post hoc “t” para-
metric test (Student test) or the non-parametric Mann-
Whitney tests were utilized. The differences were con-
sidered statistically significant when p ≤ 0.05.
Results
Morphometric and stereological evaluation
Treatment with CBZ caused a significant decrease in the
ventral prostate absolute weight of the CBZ93 rats in
comparison to the respective C93 control rats. In addi-
tion, prostatic volume and total length of glandular
tubules also significantly diminished in the CBZ93 rats.
On the other hand, the absolute and relative weights of
the ventral prostate as well as the prostatic volume and
length of rats from the other CBZ-treated groups (CBZ43
a n dC B Z 6 3 )d i dn o ts h o ws i g n i f i c a n ts t a t i s t i c a ld i f f e r -
ences in comparison to their control groups (Table 1).
R e d u c t i o n so ft h ev o l u m eo ft h ev e n t r a lp r o s t a t e
glandular lumen, and of glandular epithelium and fibro-
muscular stroma were also observed in the CBZ93
group comparatively to their respective control rats
(Table 2). Moreover, a decrease in the surface density
(Sv) and surface (S) of the epithelium of the glandular
tubules were also noted in the CBZ93 group (Figures 1
and 2).
The volume and volume density of the ventral pros-
tate lumen, epithelium of the glandular tubules and
stroma compartments of the CBZ63 and CBZ43 did not
show significant alterations in comparison with the con-
trol rats of the same age (data not shown).
Histological analysis and numerical densities of mast cells
and macrophages
The sections of the rat ventral prostate of all control and
CBZ-treated groups showed acini surrounded by a fibro-
muscular stroma, which frequently showed secretion
within the lumen. In all groups, the mucosa of the ventral
prostate was typically folded showing tall columnar
secretory epithelial cells (Figures 3A, E). In the fibromus-
cular stroma, layers of smooth muscle fibers were
observed involving the acini; outer and extensive connec-
tive tissue surrounded these structures (Figures 3A-F).
Mast cells were found in the stroma of the control (Fig-
ures 3A, C, E) and CBZ-treated animals (Figures 3B, D, F
and 4A-C). However, cytoplasm of mast cells showed
accentuated granules in CBZ43 (Figure 3B) and CBZ63
groups (Figures 3D and 4B, C). Frequently, the granules
appeared to be releasing into the connective tissue, sug-
gesting an activation of the mast cells (Figure 3D and
4C). Nevertheless, the CBZ93 rats (Figure 3F) showed
mast cells with similar morphological characteristics
when compared to those of the C93 control group (Fig-
ure 3E). Moreover, the numerical density of mast cells
was significantly higher in CBZ63 and CBZ93 groups in
comparison to corresponding controls groups (Figure 5).
Macrophages were also located in the fibromuscular
stroma of the control and CBZ-treated animals with 43,
63 and 93 days (Figures 6A, B). However, although the
macrophage numerical density of the CZB63 group has
shown a significant increase in comparison to the C63
control group, an evident reduction of this parameter
occurred in the 93-day old CBZ-treated rats in relation
to the C93 control rats (Figure 7).
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The ventral prostate AR immunoreactivity presented the
same pattern of staining in the following control and
treated groups: C43 and CBZ43; C63 and CBZ63 (Fig-
ures 8A-D). However, AR immunoreactivity was dimin-
ished in the CBZ93 group in relation to C93 control
group (Figures 8E, F). The optical density of nuclear
reactivity confirmed the qualitative analysis and showed
decrease in the AR reactivity in the CBZ93 group when
compared to the C93 control group (Figure 9).
Hormonal levels
Plasma testosterone levels were also significantly lower in
CBZ63 and CBZ93 rats in comparison with the C63 and
C93 control rats (Table 3). Nonetheless, the 93-day-old
CBZ-treated rats showed a significant increase in the estra-
diol plasma levels in comparison with the C93 control group,
whereas there was not significant alterations in this hormone
level in the 43-day-old and 63-day old CBZ-treated rats, in
comparison with their respective control rats (Table 3).
Discussion
In the prostate, death and cell proliferation are hormone
regulated events. During the periods of normal growth
of prostate, androgens are essential for stroma and
epithelial cell differentiation throughout branching mor-
phogenesis and ductal canalization [13,40]. At the age of
sexual maturity, the secretory activity of the epithelium
and the differentiation of smooth muscle are also main-
tained by androgens [40]. In the prostate, luminal and
basal epithelium as well as stroma and smooth muscle
cells express ARs at sexual development and hence are
capable of mediating androgen’sa c t i o n s[ 4 3 ] .T h u s ,i n
response to androgens, cells of the prostate interact in a
autocrine-paracrine way, influencing various aspects of
the growth of this gland in normal and diseased states
[13]. In fact, differential responsiveness of the prostate
to androgens has been observed in rat at different
phases of the sexual development [44,45]. On the other
hand, CBZ treatment can cause alterations in the weight
of seminal vesicle and prostate gland which are age-
dependent; this probably occurs due to the higher
responsiveness of the prostate to testosterone during the
pre-puberty and adulthood than during the puberty
[45,46]. During the pubertal period, testosterone clear-
ance may be increase and this could account for the
apparent reduction in prostate sensitivity during the
pubertal period. It is possible that the alterations in
prostate response reported are inherent to the tissue
themselves and are dependent on their own sponta-
neous maturation independent of other hormonal events
[47].
Puberty in the male rat is a complex process that
involves maturational changes in the hypothalamus,
pituitary, testes, and secondary sexual organs and in
their interrelationships. During the course of sexual
maturation, the negative feedback control systems for
the gonadotropins become less responsive to testoster-
one while the testes become more responsive to LH. In
the immature rat, testosterone can potentiate the effect
of GnRH on pituitary LH release; this response is lost
with sexual maturation. The responsiveness of the pros-
tate to testosterone is also altered with age due propor-
tion of testosterone and androstendione secreted by the
Table 1 Prostatic morphometric and stereological evaluation
Groups Absolute prostatic weight
(mg)
Relative prostatic weight
(mg/100 g b.w.)
Prostatic volume (mm
3)L v gt (1/mm
2)L gt (mm)
C43 110.50 ± 26.25 66.11 ± 14.38 110.50 ± 26.25 27.10 ± 5.61 2,97 ± 0.84
CBZ43 87.60 ± 8.56 60.08 ± 3.83 87.60 ± 8.56 32.70 ± 6.56 2.89 ± 0.77
C63 245.72 ± 21.64 83.80 ± 7.95 245.72 ± 21.64 23.10 ± 2.36 5.71 ± 1.05
CBZ63 231.00 ± 9.17 81.48 ± 5.91 231.00 ± 9.17 20.40 ± 5.99 4.70 ± 1.35
C93 423.08 ± 74.44 12.24 ± 0.32 423.08 ± 74.44 19.10 ± 2.75 8.07 ± 1.79
CBZ93 260.24 ± 46.80* 12.01 ± 0.67 260.24 ± 46.80* 21.50 ± 4.03 5.56 ± 1.47*
Data are reported as mean ± SD.
Differences statistically significant: *p ≤ 0.05
Prostate absolute and relative weights, prostate volume, length density (Lvgt) and length (Lgt) of the prostate glandular tubules in the control and CBZ-treated
groups
Table 2 Volume density (Vv) and total volume (V)
Stereological and morphometric
parameters
Groups
C93 CBZ93
Vv glandular epithelium (%) 39.14 ± 5.90 38.69 ± 4.68
Vv glandular lumen (%) 43.31 ± 9.40 41.83 ± 6.67
Vv fibromuscular stroma (%) 17.55 ± 5.34 19.49 ± 2.79
V glandular tubule epithelium (mm
3) 162.47 ± 14.99 101.11 ± 22.88*
V glandular lumen (mm
3) 188.69 ± 70.08 108.38 ± 22.26*
V fibromuscular stroma (mm
3) 71.92 ± 13.46 50.74 ± 11.86*
Data are reported as mean ± SD; n = 5. Statistically significant differences: *p
≤ 0.05
Volume density (Vv) and total volume (V) of the prostatic glandular
epithelium, glandular lumen and fibromuscular stroma in the C93 control and
CBZ93 groups
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transition in testicular steroid secretion suggest that it
may be a critical component of sexual maturation in the
male rat. An increase of androstendione appears to be
capable of delaying the maturation of the LH negative
feedback system, the prostate gland, and the GnRH self-
priming effect [46]. Moreover, the metabolism of testos-
terone and/or alterations androgen receptor activity
could be responsible for these sensibility differences
[46]. In addition, estrogens also play a physiologic role
in the prostate development with regard to program-
ming stromal cells and directing early morphogenic
events [48].
The significant reductions of ventral prostate weight
and volume observed in CBZ93 rats probably occurred
due to the CBZ-induced hormonal alteration. These
data are in accordance with our previous study [12]; in
this former study, a decrease in testosterone plasma
levels and an increase in the estrogen level were respec-
tively observed in 63 and 93 day-old rats which were
also CBZ-treated from the weaning. In addition, the
decrease in the weight of androgen-dependent organs as
the ventral prostate is consistent with the decrease in
serum levels of testosterone [13,49]. Besides, both
androgen and estrogen regulate AR at the level of
mRNA and protein. Then, abnormalities in the AR
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Figure 1 Surface density (Sv) of the glandular tubule epithelium of the (Svgt) in the prostate of control and CBZ-treated rats. Surface
density (Sv) of the glandular tubule epithelium of the (Svgt) in the prostate of control and CBZ-treated rats. Mean ± SD; n = 5. Statistically
significant differences: *p ≤ 0.05.
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Figure 2 Surface (S) of the epithelium of the prostatic glandular tubules (Sgt) in the control and CBZ-treated groups. Surface (S) of the
epithelium of the prostatic glandular tubules (Sgt) in the control and CBZ-treated groups. Mean ± SD; n = 5. Statistically significant differences:
*p ≤ 0.05.
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Page 6 of 15Figure 3 Photomicrographs of ventral prostate sections of control and CBZ treated rats at different ages. HE-method. A: Part of ventral
prostate section of 43-day old control rat, showing glandular epithelium with tall columnar secretory epithelial cells (Ep), smooth muscle layers
(thin arrow) and connective tissue (asterisks). Note the presence of no activated mast cell in the fibromuscular stroma (thick arrow). Bv: blood
vessel. Bar: 9 μm. B: Part of ventral prostate section of CBZ43 rat. Note the mast cell in the fibromuscular stroma with visible cytoplasmatic
granules (thick arrow). Bar: 9 μm. C: Part of ventral prostate section of a 63-day old control rat, showing detail of the fibromuscular stroma
(asterisk) containing mast cell (thick arrow) with no conspicuous cytoplasmatic granules. Bar: 9 μm. D: Ventral prostate section of the CBZ63 rat.
Note the various mast cells in process of degranulation (thick arrows) disposed in the fibromuscular stroma (asterisk). Bar: 10 μm. E and F: Ventral
prostate sections of C93 and CBZ93 rats. Note the smooth muscle layers (thin arrows) and the connective tissue (asterisks) containing the mast
cells with fine and few evident cytoplasmatic granules (head arrows). Bar: 7 μm and 7 μm, respectively.
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ductive alterations [50,51]. Moreover, post-transcrip-
tional regulation through stability of the mRNA product
is believed to be a major mechanism of androgens’
effects [52]. In the current work, the CBZ treatment
caused decrease in the AR reactivity of the 93-day old
rat prostate; this event was confirmed by the optical
density of nuclear reactivity. Prins and Birch [50]
Figure 4 Photomicrographs of ventral prostate sections of CBZ-treated rats at different ages. Toluidine blue method. A:P a r to fv e n t r a l
prostate sections of the CBZ93 rat showing the fibromuscular stroma with mast cells (arrows) around blood vessel (Bv). Bar: 20 μm. B and C:
Ventral prostate sections of the CBZ63 rats. Note mast cells with fine cytoplasmatic granules (4b, head arrows), mast cells in degranulation
process (4c, arrows) and cytoplasmatic granules (asterisks) distributed into the fibromuscular stroma. Bar: 18 μm and 11 μm, respectively.
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Figure 5 Numerical density of the mast cells in the prostatic fibromuscular stroma in the control and CBZ-treated groups. Mean ± SD;
n = 5. Statistically significant differences: *p ≤ 0.05.
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Page 8 of 15observed that neonatal chronic estrogen exposure
resulted in an immediate and sustained decrease in AR
protein levels in the developing and adult rat ventral
prostate that in turn led to its abnormal growth and
decreased secretory capacity.
In this present study, an increase of the estrogen plasma
levels during puberty phase was observed in CBZ-treated
rats. In addition, the estrogen plasma levels remained high
in the adulthood and this phenomenon probably corrobo-
rated the reduction of the morphometric and stereological
Figure 6 Photomicrographs of ventral prostate sections of CBZ43 and CBZ63 rats, respectively. A and B: Observe the positive staining
macrophages (arrows) disposed in the fibromuscular stroma (asterisks). Perl’s solution. Bar: 11 μm and 13 μm, respectively.
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Figure 7 Numerical density (Nv) of the macrophage on prostatic stroma fibromuscular in the control and CBZ-treated groups. Mean ±
SD; n = 5. Statistically significant differences: *p ≤ 0.05.
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Page 9 of 15Figure 8 Photomicrographs of ventral prostate sections of control and CBZ- treated rats at different ages submitted to AR IHC. Brown
stain signifies AR positive reactivity. Observe immuno-stainable AR located in the nuclei of cells in the prostate epithelium (arrows); AR immuno-
localization showed decrease in staining intensity in 93- day old CBZ-treated rats when compared with their control rats. Ep: glandular
epithelium; Lu: glandular lumen. Bars: 15 μm.
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Page 10 of 15parameters evaluated. In fact, a decrease in the glandular
acini length as well as in the glandular lumen, glandular
epithelium and fibromuscular stroma volumes were
observed in the CBZ93 group. These phenomena resulted
in a reduction of the ventral prostate weight and volume
in rats of this group. Additionally, we suggested that the
reduction of glandular epithelium surface was a conse-
quence of the diminution of the glandular epithelium
volume. Thus, although CBZ chronic treatment since
weaning has induced significant prostatic alterations
observed in adult rats, the harm was started from the pre-
puberty phase.
Similar to androgens, circulating levels of estradiol are
high during the fetal and early neonatal life in both
humans and rodent models [53] and there is compelling
evidence that the developing prostate gland is particu-
larly sensitive to these estrogens. Although the natural
role for estrogens during prostatic development is
unclear, it has been proposed that excessive estrogeniza-
tion during prostatic development may contribute to the
high incidence of benign prostatic hyperplasia and pro-
static carcinoma [54]. Following neonatal exposure to
high-dose estradiol, both epithelial and stromal cell pro-
liferation and differentiation are markedly disturbed
leading to defects that persist throughout the lifespan of
the animal [55,56]. Neonatal estrogen exposure inter-
rupts intercellular communication and blocks certain
epithelial cells within the rat prostate from entering a
normal differentiation pathway, beyond that the activa-
tional response to androgens during adulthood is per-
manently blunted in estrogenized rats [57] and this
effect is mediated, in part, through an immediate and
permanent reduction in prostatic AR expression
[55,58-60]. Furthermore, the temporal expression pat-
terns and quantitative levels of several other members
of the steroid receptor superfamily are deregulated by
early exposure to high doses of estradiol [15].
Besides, the possible direct effects of CBZ should be
also considered as this drug is highly lipid-soluble
[8,61]. Furthermore, some drugs alter the prostatic
stroma-epithelial communication and this occurrence
may affect the expression or distribution of growth fac-
tors, steroid hormones, and their respective receptors
[13]. These phenomena corroborate the possible occur-
rence of a specific effect of the CBZ on ventral prostate,
independently from the hormonal testosterone and
estradiol level alterations caused by this drug.
Although structural alterations of the prostatic tissue
have not been noted during the histopathological analy-
sis, we could observe the presence of degranulated mast
cells in fibromuscular stroma, both in the CBZ43 and
CBZ63 rats.
There are mast cells in almost all organic systems,
including lungs, skin, heart, and gastrointestinal tract.
Depending on the organic system, differentiation state,
stage of maturation as well as pathological conditions,
mast cells can be heterogeneous in terms of their phe-
notype, functional properties, and local distribution
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Figure 9 Semi-quantitative analysis (IOD integrated optical density) of the nuclear epithelial cells AR imunoreactivity from ventral
prostate in control and CBZ-treated groups. Mean ± SD. Statistically significant differences: *p ≤ 0.05.
Table 3 Hormonal plasma levels
Groups Testosterone levels
(ng/dL)
Estradiol levels
(ng/dL)
C43 47.74 ± 8.06 17.19 ± 4.43
CBZ43 41.04 ± 6.9 24.45 ± 5.91
C63 262.64 ± 29.31 13.03 ± 1.39
CBZ63 115.11 ± 35.77* 14.03 ± 2.64
C93 373.99 ± 73.35 12.04 ± 2.32
CBZ93 267.15 ± 70.07* 18.74 ± 2.14*
Data are reported as mean ± SD.
Statistically significant differences: *p ≤ 0.05
Testosterone and estradiol plasma levels in controls (C43, C63 and C93) and
CBZ-treated rats (CBZ43, CBZ63 and CBZ93)
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Page 11 of 15[62,63]. In the ventral prostate, a quantitative analysis
revealed a correlation between the numerical density of
mast cells and the age of the rat, since their frequency
increases during pre-puberty, remaining constant in the
puberty and adult phases [64]. Mast cells participate in
inflammatory reactions, angiogenesis, extracellular
matrix reabsorption [65], fibrosis and tissue reconstruc-
tion [66]. Activated mast cells contain several inflamma-
tory mediators, such as histamine, serotonin, cytokines,
leukotrienos, prostaglandins, chemotatic substances, pla-
telet-activing factor and potent vasodilators molecules
[62]. These mastocitary products may be activated by
different stimuli such as chemical substances, drugs, free
radicals, estradiol and radiation [67]. Tobacco smoke,
for example, can directly activate mast cells and to act
releasing mediators such as histamine and tryptase,
causing degranulation of mast cells [68,69].
The hormonal status may also induce activation and
degranulation of mast cells. Estrogens can induce rat
prostate inflammation [70] and then, mast cells can
undergo degranulation [71]. Many experimental studies
showed that steroid sexual hormones can influence the
immune response and allergy development, in which
estrogen is able to enhance humoral immune response
and antibody synthesis, whereas androgen seems to
exhibit inhibitory effects [72-74]. Therefore, the occur-
rence of activated and degranulated mast cells located in
the fibromuscular stroma, of the CBZ63 group might be
caused by alterations of the testosterone and estradiol
levels.
Since changes of the testosterone or estradiol plasma
levels this age were not at 43 days of age, the presence
of activated and degranulated mast cells in the prostatic
stroma of CBZ43 rats cannot be only explained based
on hormonal alterations. Thus, in the our experiment,
the frequent observation of activated and degranulated
mast cells located in the fibromuscular stroma of the
CBZ43 and CBZ63 groups again suggests that a direct
effect of the CBZ on ventral prostate may have
occurred, inducing possible transitory inflammatory pro-
cess. In fact, mast cells granules containing preformed
tumor necrosis factor a and releasing this cytokine from
mast cells is important for the initiation of an inflamma-
tory response [75].
Some experiments indicate that mast cell infiltration
can enhance carcinogenesis [76,77]. Mast cells contri-
bute to the development of skin cancer in K14-HPV16
transgenic mouse by proteases releasing, such as tryp-
tase and chymase and stimulating angiogenesis [78].
In addition, the presence of degranulated mast cells in
the prostatic stroma of CBZ63 rats was followed by
increase of the macrophages number. This increase of
macrophages might partly be due to the cytokines
released from infiltrating mast cells. Macrophages have
shown clearly to aid in both the initiation and progres-
sion of experimental cancers [79]. Similar increases in
mast cells and macrophages were observed in rats expo-
sure to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyri-
dine (PhIP), a heterocyclic amine in cooked meat at
high temperatures [80]; then, the inflammatory response
to PhIP may help explain the tissue-specific and prostate
lobe-specific carcinogenesis in the rat prostate induced
by a long term dietary carcinogen [81]. Moreover, after
castration, an increase of the mast cells can be observed
in the rat prostate; besides, the number of ED-1-immu-
nostained macrophages was also markedly increased in
the epithelium and in the stroma of the rat ventral pros-
tate [82].
In the present study, stereological and histomorpho-
metric analyses revealed that CBZ chronic treatment
since weaning causes, in the adult phase, decreases in:
the volume of prostatic components, glandular epithe-
lium surface and acini lenght. As a result, these altera-
tions may have probably provoked reductions of the
ventral prostate weight and volume in response to the
CBZ direct effect. Besides, testosterone and estradiol
plasma level alterations caused by CBZ can also indir-
ectly act on the ventral prostate, influencing its mainte-
nance and development. In addition, the presence of
activated mast cells during pre-puberty and puberty
phases may indicate a possible transitory inflammatory
process, suggesting direct effect of the CBZ on ventral
prostate.
In addition, we must remember that inflammatory
reactions of the male genitourinary tract can affect
male infertility in different degrees. In fact, high levels
o fc y t o k i n e ss e c r e t e db ym a s tc e l l sc a np l a yar o l ei n
the decrease of the sperm function and sperm-egg
interaction and this phenomenon have been widely
neglected so far. Moreover, cytokines does not act only
as key mediators of inflammation, but may also play
important roles in the carcinogenesis and cancer pro-
gression [83,84]. Moreover, mast cells have been used
as markers for risk stratification in invasive breast can-
cers [85,86]; then, it is possible that they can also func-
tion as cellular marker in other neoplasm, such as
prostate tumor.
Conclusions
Thus, particular attention must be drawn to the expo-
sure to environmental contaminants and therapeutic
drugs which can cause hormonal imbalances, injury and
chronic inflammation of the prostate, leading to succes-
sive infertility and prostate cancer.
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